Towards overcoming obstacles of type II photodynamic therapy: Endogenous production of light, photosensitizer, and oxygen
Author:
Funder
National Natural Science Foundation of China
Publisher
Elsevier BV
Subject
General Pharmacology, Toxicology and Pharmaceutics
Reference173 articles.
1. Clinical development and potential of photothermal and photodynamic therapies for cancer;Li;Nat Rev Clin Oncol,2020
2. Supramolecular photosensitizers rejuvenate photodynamic therapy;Li;Chem Soc Rev,2018
3. Imaging and photodynamic therapy: mechanisms, monitoring, and optimization;Celli;Chem Rev,2010
4. Overcoming the Achilles' heel of photodynamic therapy;Fan;Chem Soc Rev,2016
5. Solutions to the drawbacks of photothermal and photodynamic cancer therapy;Deng;Adv Sci,2021
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Photoferroptosis as a potent strategy for neuroblastoma treatment;Nano Today;2024-12
2. Synthesis of Coumarin-Based Photosensitizers for Enhanced Antibacterial Type I/II Photodynamic Therapy;Molecules;2024-08-10
3. Green synthesis and characterization of AgNPs, liposomal loaded AgNPs and ZnPcS4 photosensitizer for enhanced photodynamic therapy effects in MCF-7 breast cancer cells;Photodiagnosis and Photodynamic Therapy;2024-08
4. A 690-nm-excitable type I & II photosensitizer based on biotinylation of verteporfin for photodynamic therapy of deep-seated orthotopic breast tumors;Chinese Chemical Letters;2024-08
5. Unveiling new horizons: Exploring rhenium and iridium dipyrrinato complexes as luminescent theranostic agents for phototherapy;Coordination Chemistry Reviews;2024-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3